Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Surgery
|
June 1, 1993
Effects of triiodothyronine on canine hepatic ischemia caused by Pringle's maneuver
K Ino, D Manaka, M Washida, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 1, 1994
Triiodothyronine resuscitates the impaired liver function after Pringle's maneuver
S Okamoto, K Nagamatsu, A Tokuka, et al.
Transplantation
|
March 1, 1992
Maintenance of liver graft viability in the state of brain death. Synergistic effects of vasopressin and epinephrine on hepatic energy metabolism in brain-dead dogs
D Manaka, R Okamoto, T Yokoyama, et al.
The European Journal of Surgery = Acta Chirurgica
|
May 1, 1992
Decrease in arterial ketone body ratio indicating graft dysfunction after liver transplantation
Y Takada, Y Shimahara, D Manaka, et al.
Clinical Science (London, England : 1979)
|
November 1, 1991
Hepatic energy status in hypotension of different aetiologies in dogs
T Yokoyama, R Okamoto, Y Yamamoto, et al.
Transplantation
|
January 1, 1993
Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation
Y Yamaoka, M Washida, D Manaka, et al.
Clinical Transplantation
|
December 1, 1993
Living-related liver transplantation for biliary atresia
S Fujita, K Tanaka, Y Tokunaga, et al.
Transplantation
|
July 1, 1992
Beneficial effect of combined 3,5,3'-triiodothyronine and vasopressin administration of hepatic energy status and systemic hemodynamics after brain death
M Washida, R Okamoto, D Manaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2016
Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial)
M Kanai, T Kawaguchi, M Kotaka, et al.
ESMO Open
|
May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR
K Ouchi, Y Sunakawa, A Tsuji, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Surgery
|
June 1, 1993
Effects of triiodothyronine on canine hepatic ischemia caused by Pringle's maneuver
K Ino, D Manaka, M Washida, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 1, 1994
Triiodothyronine resuscitates the impaired liver function after Pringle's maneuver
S Okamoto, K Nagamatsu, A Tokuka, et al.
Transplantation
|
March 1, 1992
Maintenance of liver graft viability in the state of brain death. Synergistic effects of vasopressin and epinephrine on hepatic energy metabolism in brain-dead dogs
D Manaka, R Okamoto, T Yokoyama, et al.
The European Journal of Surgery = Acta Chirurgica
|
May 1, 1992
Decrease in arterial ketone body ratio indicating graft dysfunction after liver transplantation
Y Takada, Y Shimahara, D Manaka, et al.
Clinical Science (London, England : 1979)
|
November 1, 1991
Hepatic energy status in hypotension of different aetiologies in dogs
T Yokoyama, R Okamoto, Y Yamamoto, et al.
Transplantation
|
January 1, 1993
Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation
Y Yamaoka, M Washida, D Manaka, et al.
Clinical Transplantation
|
December 1, 1993
Living-related liver transplantation for biliary atresia
S Fujita, K Tanaka, Y Tokunaga, et al.
Transplantation
|
July 1, 1992
Beneficial effect of combined 3,5,3'-triiodothyronine and vasopressin administration of hepatic energy status and systemic hemodynamics after brain death
M Washida, R Okamoto, D Manaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2016
Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial)
M Kanai, T Kawaguchi, M Kotaka, et al.
ESMO Open
|
May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR
K Ouchi, Y Sunakawa, A Tsuji, et al.
Page
of 2